pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
TRX-319
Primary Progressive Multiple Sclerosis (PPMS)
Tr1X Inc
0 catalysts
Phase 2
TSC-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRXTScan Therapeutics, Inc.
0 catalysts
Phase 2
TSC-101
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRXTScan Therapeutics, Inc.
0 catalysts
Phase 2
← prev
page 28 of 50
next →
131
Pain89
Neurology1
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
0 catalysts
Phase 2
TSRA-196
Alpha-1 Antitrypsin Deficiency (A1AD)
Tessera Therapeutics Inc
0 catalysts
Phase 2
TST-003
Metastatic Colorectal Cancer
Transcenta Holding Ltd
0 catalysts
Phase 2
TTAX-03
Osteoarthritis Pain
BioTissue Inc
0 catalysts
Phase 2
TTHX-1114
Fuchs Endothelial Corneal Dystrophy (FECD)
Trefoil Therapeutics LLC
0 catalysts
Phase 2
TTI-101
Metastatic Hepatocellular Carcinoma (HCC)
$TVRDTvardi Therapeutics, Inc.
0 catalysts
Phase 2
TTP-273
Type 2 Diabetes
$VTVTvTv Therapeutics Inc.
0 catalysts
Phase 2
TTX-181
Batten Disease
Tern Therapeutics LLC
0 catalysts
Phase 2
TTX-333
Evitar
Scar
Temple Therapeutics BV
0 catalysts
Phase 2
TTXMC-138
Solid Tumor
$RNAZTranscode Therapeutics, Inc.
0 catalysts
Phase 2
TUB-040
Non-Small Cell Lung Cancer
Tubulis GmbH
0 catalysts
Phase 2
TVI-Kidney-1
Renal Cell Carcinoma
TVAX Biomedical Inc
0 catalysts
Phase 2
TX-45
Pulmonary Hypertension
$TECXTectonic Therapeutic, Inc.
0 catalysts
Phase 2
Temferon
Glioblastoma Multiforme (GBM)
Genenta Science SpA
0 catalysts
Phase 2
Tolasure
Epidermolysis Bullosa Simplex
Biomendics LLC
0 catalysts
Phase 2
Tregcel
Kidney Transplant Rejection
Singulera Therapeutics Inc
0 catalysts
Phase 2
UB-311
Alzheimer's Disease
Vaxxinity Inc
0 catalysts
Phase 2
UB-941
Colon Cancer
UBI Pharma Inc
0 catalysts
Phase 2
UBT-251
Obesity
Novo Nordisk AS
0 catalysts
Phase 2
UNDC-005
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Myra EB Systems LLC
0 catalysts
Phase 2
Umedaptanib Pegol
Wet (Neovascular / Exudative) Macular Degeneration
Ribomic Inc
0 catalysts
Phase 2
V-181
Dengue Fever
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
VAX-24
Streptococcal Pneumonia
$PCVXVaxcyte, Inc.
0 catalysts
Phase 2
VB-1953
Acne Vulgaris
$HINDVyome Holdings, Inc
0 catalysts
Phase 2
VBC-103
Metastatic Transitional (Urothelial) Tract Cancer
Avenzo Therapeutics Inc
0 catalysts
Phase 2
VBI-1901
Recurrent Glioblastoma Multiforme (GBM)
VBI Vaccines Inc
0 catalysts
Phase 2
VC-01
Type 1 Diabetes (Juvenile Diabetes)
$VERXVertex, Inc.
0 catalysts